Related Experiment Video
Updated: Jun 3, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Selective anticancer activity of β-lactams derived from polyaromatic compound
Bimal K Banik1, Frederick F Becker
1Department of Chemistry, The University of Texas Pan American, Edinburg, TX 78539, USA. banik@panam.edu.
Molecular Medicine Reports
|April 8, 2011
Summary
Researchers developed novel chrysene beta-lactams as anticancer agents. These compounds show selective G2 cell cycle blockage in tumor cells, offering a promising alternative to current cytotoxic drugs.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Conventional anticancer drugs harm both normal and cancerous cells, necessitating the development of targeted therapies.
- Previous research established synthetic routes for beta-lactams derived from polyaromatic amines with anticancer properties.
- Novel racemic beta-lactams have shown potential as anticancer agents, inducing G2 cell cycle arrest in sensitive tumor cell lines.
Purpose of the Study:
- To synthesize and evaluate the selective biological activities of chrysene beta-lactams.
- To explore chrysene beta-lactams as a new class of anticancer agents with improved selectivity.
- To investigate the mechanism of action, specifically cell cycle effects, of these novel compounds.
Main Methods:
- Synthesis of novel beta-lactam derivatives incorporating the chrysene moiety.
- In vitro biological evaluation of synthesized compounds against various tumor cell lines.
- Cell cycle analysis using flow cytometry to determine the effects on cell division.
Main Results:
- Chrysene beta-lactams exhibited significant and selective anticancer activity.
- Compounds demonstrated a G2 phase cell cycle blockage in sensitive tumor cell lines.
- The study identified specific chrysene beta-lactam structures with promising therapeutic potential.
Conclusions:
- Chrysene beta-lactams represent a promising new class of anticancer agents with selective activity.
- The observed G2 cell cycle arrest mechanism offers a targeted approach to cancer therapy.
- Further investigation into chrysene beta-lactams could lead to the development of novel chemotherapeutic drugs.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
00:57Antibiotic Selection
Overview
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...